One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety profile in a once daily pill for moderate-to-severe plaque psoriasis ...
Neuroscience reveals four simple tips to make your audience pay attention. If present, your audience tunes in—if absent, you've lost them.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results